Senate Democrats Delay HHS Nominee Over Women’s Health Funding
Sen. Patty Murray questions Dr. Brett Giroir’s willingness to stand up for women’s health programs such as family planning services and teenage pregnancy prevention.
The independent source for health policy research, polling, and news.
2,521-2,540 of 4,002 results
Sen. Patty Murray questions Dr. Brett Giroir’s willingness to stand up for women’s health programs such as family planning services and teenage pregnancy prevention.
The new law will help people with chronic conditions that require multiple prescriptions cut down on their shuttles to the drug store and could improve adherence to their drugs.
Federal records show that 2,573 hospitals around the country will have their Medicare payments reduced because they have too many patients readmitted.
Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.
The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. The exchange also announced that Anthem Blue Cross will pull out of Covered California and the overall individual market in 16 of the 19 regions it currently serves.
The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
A Wisconsin lawsuit alleges United Healthcare downplayed abusive sales tactics to avoid losing government bonuses.
Dr. Sanjay Mishra, the husband of CMS Administrator Seema Verma, is part of a group practice in Indiana that does not accept Medicaid payments.
In the first case of its kind in the U.S., the company was ordered to pay damages to the hospital where a patient died of an infection linked to a contaminated scope. But jurors also found the hospital negligent, and it was ordered to pay the patients' family $1 million.
In a head-to-head comparison, several of the cheaper devices performed nearly as well as the expensive hearing aids. The study lends credence to lawmakers’ efforts to get the FDA to set standards for over-the-counter versions.
A coalition of health care providers are blocking Ohio’s law requiring health care providers to tell what non-emergency services will cost them.
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
Tennessee and Virginia regulators are considering approval of a merger between Mountain States Health Alliance and Wellmont Health System under their state laws. If they allow it, the Federal Trade Commission would be powerless to stop it.
Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Sarah Kliff of Vox.com, and Margot Sanger-Katz of The New York Times discuss the ever-changing status of the Senate’s effort to “repeal and replace” the Affordable Care Act, and the Trump administration’s efforts to undermine the working of the law.
Where women prefer to go for health care becomes a proxy for the abortion debate.
At a hearing Wednesday, federal health officials pointed to billing errors, fraud and overcharges that led Medicare to overpay by staggering sums.
Fewer than 8 percent of enrollees in medical studies are Hispanic. Those who don't participate have less access to cutting-edge treatments, and researchers have less data on how a drug works within the Hispanic population.
The controversial 340B drug discount program for hospitals came under fire at a congressional hearing.
The controversial practice — done by just a few other states — recently cast a spotlight on some prominent doctors. Supporters say it improves performance; detractors warn it discourages taking on complex cases.
© 2026 KFF